| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80 | 4.06e-07 | 343 | 90 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80 | 6.82e-06 | 459 | 90 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1 | 7.71e-06 | 465 | 90 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | channel activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80 | 2.38e-05 | 525 | 90 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80 | 2.43e-05 | 526 | 90 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | calcium channel activity | 2.58e-05 | 129 | 90 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.11e-05 | 14 | 90 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1 UNC80 | 4.23e-05 | 664 | 90 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.25e-05 | 151 | 90 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 6.48e-05 | 152 | 90 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 ABCA6 KCNV2 PKD1 SLC4A10 ABCB11 KCNS1 CNGB1 SLC16A12 UNC80 SLC2A5 | 6.80e-05 | 1180 | 90 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | small GTPase binding | 1.01e-04 | 321 | 90 | 8 | GO:0031267 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1 | 1.18e-04 | 627 | 90 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.74e-04 | 182 | 90 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.85e-04 | 184 | 90 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 ABCA6 KCNV2 PKD1 SLC4A10 ABCB11 KCNS1 CNGB1 SLC16A12 UNC80 SLC2A5 | 1.90e-04 | 1289 | 90 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | GTPase binding | 2.21e-04 | 360 | 90 | 8 | GO:0051020 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1 UNC80 | 2.26e-04 | 793 | 90 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1 | 5.95e-04 | 758 | 90 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | gated channel activity | 7.84e-04 | 334 | 90 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.17e-03 | 46 | 90 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | GDP-dissociation inhibitor activity | 2.61e-03 | 17 | 90 | 2 | GO:0005092 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP PKD1 NIPSNAP2 PLCH1 CNGB1 PLCE1 | 1.10e-06 | 392 | 90 | 11 | GO:0070588 |
| GeneOntologyBiologicalProcess | calcium ion transport | JPH1 CACNA1C CACNA1E CACNA1F SCN11A IL16 TRPC4AP PKD1 NIPSNAP2 PLCH1 CNGB1 PLCE1 | 2.14e-06 | 509 | 90 | 12 | GO:0006816 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 UNC80 PLCE1 | 2.82e-06 | 942 | 90 | 16 | GO:0098655 |
| GeneOntologyBiologicalProcess | metal ion transport | JPH1 CACNA1C CACNA1E CACNA1F SCN11A IL16 TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 PLCE1 | 6.04e-06 | 1000 | 90 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | JPH1 CACNA1C CACNA1E CACNA1F SCN11A IL16 TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 UNC80 PLCE1 | 9.16e-06 | 1157 | 90 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 PLCE1 | 1.01e-05 | 922 | 90 | 15 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 UNC80 PLCE1 | 2.34e-05 | 1115 | 90 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 PLCE1 | 3.18e-05 | 1017 | 90 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | organelle localization | STX19 SCN11A KAT5 KCNB1 MYO5B ATCAY PKD1 ASPM SPO11 ATM XPO1 SDAD1 | 5.38e-05 | 703 | 90 | 12 | GO:0051640 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | JPH1 CACNA1C CACNA1E CACNA1F SCN11A IL16 TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 UNC80 PLCE1 | 8.13e-05 | 1374 | 90 | 17 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of DNA stability | 1.12e-04 | 4 | 90 | 2 | GO:0097752 | |
| GeneOntologyBiologicalProcess | signal transduction in response to DNA damage | 2.44e-04 | 200 | 90 | 6 | GO:0042770 | |
| GeneOntologyCellularComponent | cation channel complex | CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80 | 6.23e-08 | 235 | 89 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80 | 4.74e-06 | 378 | 89 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80 | 7.64e-05 | 523 | 89 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80 | 1.16e-04 | 550 | 89 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | calcium channel complex | 2.67e-04 | 73 | 89 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | microtubule minus-end | 3.71e-04 | 7 | 89 | 2 | GO:0036449 | |
| GeneOntologyCellularComponent | perikaryon | 3.83e-04 | 223 | 89 | 6 | GO:0043204 | |
| GeneOntologyCellularComponent | chromosomal region | 4.31e-04 | 421 | 89 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 9.37e-04 | 176 | 89 | 5 | GO:0000781 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 9.92e-04 | 46 | 89 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.58e-03 | 14 | 89 | 2 | GO:0005642 | |
| Domain | Channel_four-helix_dom | 9.56e-09 | 57 | 89 | 7 | IPR027359 | |
| Domain | - | 9.56e-09 | 57 | 89 | 7 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 7.04e-08 | 114 | 89 | 8 | IPR005821 | |
| Domain | Ion_trans | 7.04e-08 | 114 | 89 | 8 | PF00520 | |
| Domain | VDCC_a1su_IQ | 3.61e-06 | 7 | 89 | 3 | IPR014873 | |
| Domain | GPHH | 3.61e-06 | 7 | 89 | 3 | PF16905 | |
| Domain | GPHH_dom | 3.61e-06 | 7 | 89 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 3.61e-06 | 7 | 89 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 3.61e-06 | 7 | 89 | 3 | PF08763 | |
| Domain | ARM-type_fold | 4.85e-06 | 339 | 89 | 10 | IPR016024 | |
| Domain | VDCCAlpha1 | 1.23e-05 | 10 | 89 | 3 | IPR002077 | |
| Domain | CABLES1/2 | 2.25e-05 | 2 | 89 | 2 | IPR012388 | |
| Domain | CAC1F_C | 6.72e-05 | 3 | 89 | 2 | IPR031688 | |
| Domain | CAC1F_C | 6.72e-05 | 3 | 89 | 2 | PF16885 | |
| Domain | VDCC_L_a1su | 1.34e-04 | 4 | 89 | 2 | IPR005446 | |
| Domain | MOZ_SAS | 2.22e-04 | 5 | 89 | 2 | PF01853 | |
| Domain | HAT_MYST-type | 2.22e-04 | 5 | 89 | 2 | IPR002717 | |
| Domain | MYST_HAT | 2.22e-04 | 5 | 89 | 2 | PS51726 | |
| Domain | K_chnl_volt-dep_Kv | 2.82e-04 | 27 | 89 | 3 | IPR003968 | |
| Domain | ARM-like | 3.06e-04 | 270 | 89 | 7 | IPR011989 | |
| Domain | K_chnl_volt-dep_Kv9 | 4.64e-04 | 7 | 89 | 2 | IPR003971 | |
| Domain | CAMSAP_CH | 4.64e-04 | 7 | 89 | 2 | PF11971 | |
| Domain | CAMSAP_CH | 4.64e-04 | 7 | 89 | 2 | IPR022613 | |
| Domain | VG_K_chnl | 5.15e-04 | 33 | 89 | 3 | IPR028325 | |
| Domain | Ran_BP1 | 1.44e-03 | 12 | 89 | 2 | PF00638 | |
| Domain | RANBD1 | 1.44e-03 | 12 | 89 | 2 | PS50196 | |
| Domain | RanBD | 1.69e-03 | 13 | 89 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 1.69e-03 | 13 | 89 | 2 | IPR000156 | |
| Domain | BTB_2 | 2.06e-03 | 53 | 89 | 3 | PF02214 | |
| Domain | T1-type_BTB | 2.06e-03 | 53 | 89 | 3 | IPR003131 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.26e-03 | 15 | 89 | 2 | IPR001711 | |
| Domain | EF-hand_like | 2.26e-03 | 15 | 89 | 2 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 2.26e-03 | 15 | 89 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 2.26e-03 | 15 | 89 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.26e-03 | 15 | 89 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 2.26e-03 | 15 | 89 | 2 | PF00387 | |
| Domain | PLCYc | 2.26e-03 | 15 | 89 | 2 | SM00149 | |
| Domain | EF-hand-dom_pair | 2.50e-03 | 287 | 89 | 6 | IPR011992 | |
| Domain | HEAT | 2.67e-03 | 58 | 89 | 3 | IPR000357 | |
| Domain | PI-PLC-X | 3.27e-03 | 18 | 89 | 2 | PF00388 | |
| Domain | PLCXc | 3.27e-03 | 18 | 89 | 2 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 3.64e-03 | 19 | 89 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 3.64e-03 | 19 | 89 | 2 | IPR000909 | |
| Domain | - | 4.19e-03 | 222 | 89 | 5 | 1.25.10.10 | |
| Domain | Kinase-like_dom | 4.31e-03 | 542 | 89 | 8 | IPR011009 | |
| Domain | HEAT_REPEAT | 4.55e-03 | 70 | 89 | 3 | PS50077 | |
| Domain | IQ | 4.73e-03 | 71 | 89 | 3 | PF00612 | |
| Pathway | WP_GPR40_PATHWAY | 4.69e-05 | 15 | 68 | 3 | M39526 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.77e-04 | 23 | 68 | 3 | M47666 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 1.85e-04 | 59 | 68 | 4 | M261 | |
| Pathway | BIOCARTA_RAN_PATHWAY | 2.27e-04 | 5 | 68 | 2 | M22082 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 2.29e-04 | 25 | 68 | 3 | M47948 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 2.58e-04 | 26 | 68 | 3 | MM15297 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 3.20e-04 | 271 | 68 | 7 | MM15388 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 3.40e-04 | 6 | 68 | 2 | M27585 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 3.40e-04 | 6 | 68 | 2 | MM15295 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 3.40e-04 | 6 | 68 | 2 | M47762 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 4.91e-04 | 291 | 68 | 7 | M16647 | |
| Pathway | BIOCARTA_PLK3_PATHWAY | 6.30e-04 | 8 | 68 | 2 | M22021 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 7.42e-04 | 37 | 68 | 3 | M27038 | |
| Pathway | BIOCARTA_CDC25_PATHWAY | 8.08e-04 | 9 | 68 | 2 | M22031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 8.08e-04 | 9 | 68 | 2 | M47586 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.00e-03 | 41 | 68 | 3 | MM14546 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 1.01e-03 | 92 | 68 | 4 | MM15338 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 1.01e-03 | 92 | 68 | 4 | M27636 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 1.01e-03 | 10 | 68 | 2 | M47572 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 1.15e-03 | 43 | 68 | 3 | M27588 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.15e-03 | 43 | 68 | 3 | M1056 | |
| Pathway | REACTOME_PEXOPHAGY | 1.23e-03 | 11 | 68 | 2 | M29846 | |
| Pathway | PID_RANBP2_PATHWAY | 1.23e-03 | 11 | 68 | 2 | M140 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.23e-03 | 11 | 68 | 2 | M47958 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 8.56e-08 | 139 | 91 | 7 | 16985003 | |
| Pubmed | 6.02e-07 | 7 | 91 | 3 | 12900400 | ||
| Pubmed | 9.61e-07 | 8 | 91 | 3 | 16705183 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CFLAR CDK17 RANBP1 RANBP2 VAC14 GANAB HTR1E TELO2 MARK3 CENPH ASPM NIPSNAP2 MCM5 CDK14 SDAD1 | 1.17e-06 | 1284 | 91 | 15 | 17353931 |
| Pubmed | 1.44e-06 | 9 | 91 | 3 | 16382099 | ||
| Pubmed | 1.44e-06 | 9 | 91 | 3 | 10601307 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | JPH1 CDK17 RANBP1 RANBP2 TRPC4AP GANAB INF2 ASPM CHEK1 ATM XPO1 GDI2 AQR THAP11 | 1.81e-06 | 1155 | 91 | 14 | 20360068 |
| Pubmed | 2.82e-06 | 11 | 91 | 3 | 11551930 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 4.46e-06 | 475 | 91 | 9 | 31040226 | |
| Pubmed | CACNA1C CACNA1E RANBP1 RANBP2 SCN11A PHACTR2 MYO5B ASPM NIPSNAP2 MCM5 ZBTB41 ATM ZFC3H1 PLCH1 CAMSAP2 | 4.85e-06 | 1442 | 91 | 15 | 35575683 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 32015129 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 12973680 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24294372 | ||
| Pubmed | A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. | 6.77e-06 | 2 | 91 | 2 | 16141325 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 34535971 | ||
| Pubmed | Mammalian meiosis involves DNA double-strand breaks with 3' overhangs. | 6.77e-06 | 2 | 91 | 2 | 12644952 | |
| Pubmed | Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability. | 6.77e-06 | 2 | 91 | 2 | 25888683 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 18497861 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 34063002 | ||
| Pubmed | Atm-dependent interactions of a mammalian chk1 homolog with meiotic chromosomes. | 6.77e-06 | 2 | 91 | 2 | 9382850 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19401701 | ||
| Pubmed | ATM and KAT5 safeguard replicating chromatin against formaldehyde damage. | 6.77e-06 | 2 | 91 | 2 | 26420831 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 36293397 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24040138 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 33802342 | ||
| Pubmed | De novo deletions and duplications at recombination hotspots in mouse germlines. | 6.77e-06 | 2 | 91 | 2 | 34793701 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 28600321 | ||
| Pubmed | 7.71e-06 | 15 | 91 | 3 | 20188150 | ||
| Pubmed | 7.71e-06 | 15 | 91 | 3 | 24453333 | ||
| Pubmed | 1.11e-05 | 288 | 91 | 7 | 23383273 | ||
| Pubmed | 1.53e-05 | 421 | 91 | 8 | 36976175 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 25028520 | ||
| Pubmed | Electrically silent potassium channel subunits from human lens epithelium. | 2.03e-05 | 3 | 91 | 2 | 10484328 | |
| Pubmed | The tumor suppressor, TAX1BP2, is a novel substrate of ATM kinase. | 2.03e-05 | 3 | 91 | 2 | 24240686 | |
| Pubmed | Key mediators of somatic ATR signaling localize to unpaired chromosomes in spermatocytes. | 2.03e-05 | 3 | 91 | 2 | 26209650 | |
| Pubmed | Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway. | 2.03e-05 | 3 | 91 | 2 | 20581453 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 30962349 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 25234309 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 11527406 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 20514472 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 9111043 | ||
| Pubmed | Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. | 2.03e-05 | 3 | 91 | 2 | 11780126 | |
| Pubmed | An allosteric mechanism to displace nuclear export cargo from CRM1 and RanGTP by RanBP1. | 2.03e-05 | 3 | 91 | 2 | 20485264 | |
| Pubmed | Two distinct classes of Ran-binding sites on the nucleoporin Nup-358. | 2.03e-05 | 3 | 91 | 2 | 10318915 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 31074776 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 10330396 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 12676962 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 17611684 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 23333640 | ||
| Pubmed | ATM pathway activation limits R-loop-associated genomic instability in Werner syndrome cells. | 2.03e-05 | 3 | 91 | 2 | 30657978 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 14637168 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 33597309 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 16603769 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 30820446 | ||
| Pubmed | ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells. | 2.03e-05 | 3 | 91 | 2 | 17932249 | |
| Pubmed | Thymidylate kinase is critical for DNA repair via ATM-dependent Tip60 complex formation. | 2.03e-05 | 3 | 91 | 2 | 30199284 | |
| Pubmed | Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. | 2.03e-05 | 3 | 91 | 2 | 16041368 | |
| Pubmed | 2.63e-05 | 65 | 91 | 4 | 29150431 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.02e-05 | 759 | 91 | 10 | 35915203 | |
| Pubmed | JPH1 CDK17 GANAB FAM193A TELO2 INF2 MARK3 SUPT6H TRABD ASPM ATM ZFC3H1 PLCH1 AQR | 3.14e-05 | 1487 | 91 | 14 | 33957083 | |
| Pubmed | Distinct RanBP1 nuclear export and cargo dissociation mechanisms between fungi and animals. | 4.05e-05 | 4 | 91 | 2 | 31021318 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 21041529 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 26061604 | ||
| Pubmed | ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. | 4.05e-05 | 4 | 91 | 2 | 11390642 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 21532626 | ||
| Pubmed | NOTCH1 Inhibits Activation of ATM by Impairing the Formation of an ATM-FOXO3a-KAT5/Tip60 Complex. | 4.05e-05 | 4 | 91 | 2 | 27524627 | |
| Pubmed | RanBP1 stabilizes the interaction of Ran with p97 nuclear protein import. | 4.05e-05 | 4 | 91 | 2 | 8909533 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 17980166 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 15998665 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 16055729 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 19903823 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 20937870 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 18381943 | ||
| Pubmed | Isolated polycystic liver disease genes define effectors of polycystin-1 function. | 4.05e-05 | 4 | 91 | 2 | 28375157 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 18317468 | ||
| Pubmed | Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60. | 4.05e-05 | 4 | 91 | 2 | 19783983 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 28808232 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 34838521 | ||
| Pubmed | The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. | 4.05e-05 | 4 | 91 | 2 | 21034966 | |
| Pubmed | GTP hydrolysis links initiation and termination of nuclear import on the nucleoporin nup358. | 4.05e-05 | 4 | 91 | 2 | 10473610 | |
| Pubmed | Facilitated nucleocytoplasmic shuttling of the Ran binding protein RanBP1. | 4.05e-05 | 4 | 91 | 2 | 10779340 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 12676583 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 11875057 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 22002603 | ||
| Pubmed | XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer. | 4.05e-05 | 4 | 91 | 2 | 29082250 | |
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 5.41e-05 | 28 | 91 | 3 | 24462114 | |
| Pubmed | 6.03e-05 | 29 | 91 | 3 | 18239623 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 18480045 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 7603572 | ||
| Pubmed | Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. | 6.74e-05 | 5 | 91 | 2 | 18536714 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 16675955 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 29760279 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 21355037 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 10859164 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 11252893 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 15451373 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 12955071 | ||
| Pubmed | ik3-2, a relative to ik3-1/cables, is associated with cdk3, cdk5, and c-abl. | 6.74e-05 | 5 | 91 | 2 | 11955625 | |
| Pubmed | The Rad50 hook domain regulates DNA damage signaling and tumorigenesis. | 6.74e-05 | 5 | 91 | 2 | 24532689 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 31663850 | ||
| Interaction | MCPH1 interactions | 5.66e-06 | 101 | 89 | 6 | int:MCPH1 | |
| Interaction | EGLN3 interactions | CDK17 RANBP1 RANBP2 VAC14 GANAB FAM193A TELO2 TRABD IQCB1 ASPM MIOS NIPSNAP2 MCM5 XPO1 PLCH1 CDK14 CAMSAP2 EPAS1 | 1.21e-05 | 1296 | 89 | 18 | int:EGLN3 |
| GeneFamily | Calcium voltage-gated channel subunits | 7.34e-05 | 26 | 57 | 3 | 253 | |
| GeneFamily | Potassium voltage-gated channels | 2.70e-04 | 40 | 57 | 3 | 274 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 1.14e-03 | 16 | 57 | 2 | 66 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.29e-03 | 17 | 57 | 2 | 486 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.61e-03 | 19 | 57 | 2 | 832 | |
| GeneFamily | Cyclin dependent kinases | 3.02e-03 | 26 | 57 | 2 | 496 | |
| GeneFamily | SH2 domain containing | 3.98e-03 | 101 | 57 | 3 | 741 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-08 | 169 | 91 | 7 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-07 | 184 | 91 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-07 | 184 | 91 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-07 | 184 | 91 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-06 | 167 | 91 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.15e-06 | 184 | 91 | 6 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.10e-06 | 196 | 91 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.29e-06 | 198 | 91 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.48e-06 | 200 | 91 | 6 | 97e47eb69d1d4cab45256acca9589837eb7817e7 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.48e-06 | 200 | 91 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-06 | 200 | 91 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.42e-05 | 150 | 91 | 5 | 201d5b68e71c6c003285428be96c488e6d526edf | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 73 | 91 | 4 | 3ac392ac46ad577c7d2c2b5e6a0a96ceb613097b | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 73 | 91 | 4 | 1bd6ff9659efc43b0a596da50e325bde2f0ba8f7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-05 | 161 | 91 | 5 | c54010d88f1ecb6e0235bb66084876a4d5bf1ecd | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-05 | 162 | 91 | 5 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | control-dn_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.60e-05 | 170 | 91 | 5 | 839f62860b4a52d06e6a8fce7632195c7310b89d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.24e-05 | 178 | 91 | 5 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma-Plasmablasts|blood / Manually curated celltypes from each tissue | 3.32e-05 | 179 | 91 | 5 | 7d3bd1f9e126a4a9e0a84720a6cc0b3d235e65ee | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.32e-05 | 179 | 91 | 5 | 5122fc794509492afde4af8b1b76d51e3070ef05 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 3.60e-05 | 182 | 91 | 5 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 3.69e-05 | 183 | 91 | 5 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 183 | 91 | 5 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.69e-05 | 183 | 91 | 5 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-05 | 184 | 91 | 5 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-05 | 184 | 91 | 5 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 185 | 91 | 5 | 512a195ebbae445afe3722a3943020080daf2f3c | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 3.99e-05 | 186 | 91 | 5 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 3.99e-05 | 186 | 91 | 5 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 4.09e-05 | 187 | 91 | 5 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.20e-05 | 188 | 91 | 5 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | normal-na-Lymphocytic|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.31e-05 | 189 | 91 | 5 | 1d382f8eb998c6a30e09fddc9a427afc8f5f7323 | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.31e-05 | 189 | 91 | 5 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.31e-05 | 189 | 91 | 5 | b83fd81ecc5ef363be7435ee12cb7079e2434af7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-05 | 189 | 91 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.31e-05 | 189 | 91 | 5 | 3db4177d68cab4cd16842d2ebcaca28f69300e44 | |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|Lymphoid / Condition, Lineage and Cell class | 4.53e-05 | 191 | 91 | 5 | bcdadf83cb9653f9cc2a281e7c1095fe8f79173c | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.76e-05 | 193 | 91 | 5 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.87e-05 | 194 | 91 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.99e-05 | 195 | 91 | 5 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.99e-05 | 195 | 91 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.99e-05 | 195 | 91 | 5 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | ILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.12e-05 | 196 | 91 | 5 | 6a415a2574bd84bd825a2bd6c8e3632a433ff7cf | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|World / Lineage, cell class and subclass | 5.12e-05 | 196 | 91 | 5 | 42a4d706382be33d552ece1d0598d073857a8d4e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.12e-05 | 196 | 91 | 5 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | severe-T/NK_proliferative|severe / disease stage, cell group and cell class | 5.12e-05 | 196 | 91 | 5 | 89f005216770dbb84378f5d1f20ca11b0ce40faa | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.12e-05 | 196 | 91 | 5 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | 343B-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.24e-05 | 197 | 91 | 5 | b340d6f041231e5c69140895aaa1e8d28bafb998 | |
| ToppCell | severe-T/NK_proliferative|World / disease stage, cell group and cell class | 5.24e-05 | 197 | 91 | 5 | 6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue | 5.24e-05 | 197 | 91 | 5 | 1f7c3d193647b66cce6ea202a40758cd10b8bd12 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 5.24e-05 | 197 | 91 | 5 | acd678586aa0e4375bc8fbcdaa1a796c8dd23885 | |
| ToppCell | myeloid-CD34+_Monoblast|myeloid / Lineage and Cell class | 5.37e-05 | 198 | 91 | 5 | e26b98a8380e693110a97d8e5a353998f8d67c6d | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasmablast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-05 | 198 | 91 | 5 | cfbe0bae21b6cd9cd15d3e659b618b44cfe3eaec | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.37e-05 | 198 | 91 | 5 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.37e-05 | 198 | 91 | 5 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-05 | 198 | 91 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | MS-cycling-|MS / Condition, Cell_class and T cell subcluster | 5.37e-05 | 198 | 91 | 5 | 19c5d6b65de490118574b1f86b45c58b3a51df7f | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.37e-05 | 198 | 91 | 5 | f9f083c76c51b6f014ecf80eaec957eff8d1ab75 | |
| ToppCell | MS-cycling|MS / Condition, Cell_class and T cell subcluster | 5.37e-05 | 198 | 91 | 5 | 0c22f2cc0e5ca91cabcd4aac2b9ef05af47e967f | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-11|World / Primary Cells by Cluster | 5.37e-05 | 198 | 91 | 5 | 672c6faeed54e1397e12c0aac1a5cbd19c684f06 | |
| ToppCell | BAL-Severe|BAL / Compartment, Disease Groups and Clusters | 5.37e-05 | 198 | 91 | 5 | f63cfcc57f46094ea0673bbc70ea443ebaca6176 | |
| ToppCell | severe-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.50e-05 | 199 | 91 | 5 | 6ee4c2e6049860071169366b7e662d5c1a3cc54b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.50e-05 | 199 | 91 | 5 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | remission-T/NK_proliferative|remission / disease stage, cell group and cell class | 5.50e-05 | 199 | 91 | 5 | 303a5fc43a48b05b6f2060d99eef4adc36f8d4e3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.50e-05 | 199 | 91 | 5 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 5.50e-05 | 199 | 91 | 5 | 4142d5b1b20212508f95841fdac4efb7655616cb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.50e-05 | 199 | 91 | 5 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | remission-T/NK_proliferative|World / disease stage, cell group and cell class | 5.50e-05 | 199 | 91 | 5 | f305f3a454b7d2170429bad087480ccccca19acd | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class | 5.50e-05 | 199 | 91 | 5 | 893b78c661c529db07a5fcc3124d9b3d0f270fa5 | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 5.50e-05 | 199 | 91 | 5 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.50e-05 | 199 | 91 | 5 | 5b18e18ddbf4bd53aa0d574d23092cb96da7f400 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.50e-05 | 199 | 91 | 5 | 6df65f4c2f9a125e0c7c4f597fefc05a97fc8831 | |
| ToppCell | severe-Lymphocytic-Prol._cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.50e-05 | 199 | 91 | 5 | b24315952b6ac6c8d2d3a7bd949a5b5392624d4e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.50e-05 | 199 | 91 | 5 | cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.50e-05 | 199 | 91 | 5 | f9bf94ab6b5b134f5b98a65340843b147941ab58 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 5.50e-05 | 199 | 91 | 5 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.50e-05 | 199 | 91 | 5 | 89d7622c4ae146900d963ac68c6bf011e8674665 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 5.63e-05 | 200 | 91 | 5 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.63e-05 | 200 | 91 | 5 | 7b7a5800798a3e7eba164fbc28312dd09c57a2c3 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 5.63e-05 | 200 | 91 | 5 | 9c2095dcf70f1288d55d0ff4a97efd4fd8d0c9ee | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.63e-05 | 200 | 91 | 5 | d92d3bc63a56a604d7b1d49e62d4304e5e4017f2 | |
| ToppCell | Severe-T/NK_proliferative|Severe / Disease group and Cell class | 5.63e-05 | 200 | 91 | 5 | 4723613a9f56bff422fc98722128d57b6adf3c5d | |
| ToppCell | ILEUM-inflamed-(1)_Highly_activated_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.63e-05 | 200 | 91 | 5 | 6ff811fdfe49b5b0aea0e88fae80bfaaf40eb7c4 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.63e-05 | 200 | 91 | 5 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Severe-T/NK_proliferative|World / Disease group and Cell class | 5.63e-05 | 200 | 91 | 5 | 128d82eb4d5760adf872212d8e8b5787a889969f | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 5.63e-05 | 200 | 91 | 5 | cfec2f712b870797fab3b0770f16feaafd37e8d5 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease, condition lineage and cell class | 5.63e-05 | 200 | 91 | 5 | 00538c4cbab5da00b3a366717d38a3ba5cfe3f65 | |
| ToppCell | moderate-Lymphoid-NKT-proliferating|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.63e-05 | 200 | 91 | 5 | 8692e6664f0bb2be990f7563888380bb47414626 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.63e-05 | 200 | 91 | 5 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.15e-04 | 122 | 91 | 4 | c16110934172f174f4aefe14b81abce8514b30f0 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.15e-04 | 122 | 91 | 4 | 006ac4f6807e688554d36557d29d5e5a0bc3c36f | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.15e-04 | 122 | 91 | 4 | f3d9a5893fdee3562880fb6fc132b88169a7d997 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.05e-04 | 142 | 91 | 4 | 58bfff3284ae21150e4619511bd58622c16c5dde | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.05e-04 | 142 | 91 | 4 | 5fd737c1fee9d97aee8955f1bf378ead3fce138d | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.05e-04 | 142 | 91 | 4 | 16f9945e835c3506b12d904778560d065a50f059 | |
| ToppCell | NS-critical-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.17e-04 | 144 | 91 | 4 | 0fde5cd82df9b90aefde19275cff6c2ec3c9d5cb | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Lmo2_(eccentric_SPN,_dSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.40e-04 | 59 | 91 | 3 | dbb61f03be7d2c7fa7d32c743fcff2dc91ae0d75 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Lmo2_(eccentric_SPN,_dSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.40e-04 | 59 | 91 | 3 | e6cbbe1a4961066cae8f8c03a838f37e60a5391a | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.53e-04 | 150 | 91 | 4 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | 8.36e-08 | 196 | 90 | 9 | 2974_DN | |
| Drug | NSC683246 | 3.76e-07 | 234 | 90 | 9 | CID000005097 | |
| Drug | AC1L1KS5 | 7.03e-06 | 334 | 90 | 9 | CID000005631 | |
| Drug | AC1L2AC7 | 7.94e-06 | 69 | 90 | 5 | CID000068733 | |
| Drug | CNS 1145 | 8.56e-06 | 33 | 90 | 4 | CID000190902 | |
| Drug | IHC-64 | 8.56e-06 | 33 | 90 | 4 | CID000162753 | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; HL60; HG-U133A | 1.37e-05 | 198 | 90 | 7 | 1571_DN | |
| Drug | Basic Violet 11:1 | 1.55e-05 | 2 | 90 | 2 | CID000062265 | |
| Drug | U46619 | 1.74e-05 | 285 | 90 | 8 | CID000005618 | |
| Drug | verapamil | CACNA1C CACNA1E CACNA1F KCNB1 ABCA6 MYO5B KCNV2 PKD1 ABCB11 KCNS1 | 2.39e-05 | 490 | 90 | 10 | CID000002520 |
| Drug | AC1NUZ8M | 3.24e-05 | 92 | 90 | 5 | CID000073211 | |
| Drug | [(4E)-4-[(2,2-difluoroethylamino)methylene]-6-methyl-5-oxo-3-pyridyl]methyl dihydrogen phosphate | 3.90e-05 | 17 | 90 | 3 | CID011840958 | |
| Drug | Isradipine | 4.67e-05 | 18 | 90 | 3 | ctd:D017275 | |
| Drug | ICRF-193 | 6.21e-05 | 54 | 90 | 4 | CID000115150 | |
| Drug | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | CFLAR KAT5 MYO5B PKD1 HIPK2 NIPSNAP2 MCM5 CHEK1 PLEKHG2 EPAS1 | 7.12e-05 | 558 | 90 | 10 | ctd:C072553 |
| Drug | papaverine | 7.13e-05 | 176 | 90 | 6 | CID000004680 | |
| Drug | Cinildipine | 7.17e-05 | 56 | 90 | 4 | CID000002752 | |
| Drug | pyrachlostrobin | DDIAS PHACTR2 MYO5B KLHDC8A NFKB2 ASPM LRP4 ACAD10 SLFN5 PLEKHG2 EPAS1 PLCE1 | 8.23e-05 | 811 | 90 | 12 | ctd:C513428 |
| Drug | nilvadipine | 9.40e-05 | 60 | 90 | 4 | CID000004494 | |
| Drug | IAA-94 | 1.00e-04 | 61 | 90 | 4 | CID000003667 | |
| Drug | AC1NBU2S | 1.02e-04 | 117 | 90 | 5 | CID004473765 | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.03e-04 | 188 | 90 | 6 | 3325_DN | |
| Drug | EGTA-AM | 1.07e-04 | 62 | 90 | 4 | CID000121907 | |
| Drug | NSC759576 | 1.12e-04 | 191 | 90 | 6 | CID000003075 | |
| Drug | lercanidipine | 1.14e-04 | 63 | 90 | 4 | CID000065866 | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 1.25e-04 | 195 | 90 | 6 | 4148_UP | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; HL60; HG-U133A | 1.29e-04 | 196 | 90 | 6 | 1967_UP | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; HL60; HT_HG-U133A | 1.29e-04 | 196 | 90 | 6 | 3093_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 2892_UP | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 6994_UP | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 2868_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 6083_UP | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 1.36e-04 | 198 | 90 | 6 | 407_DN | |
| Drug | rosiglitazone maleate; Up 200; 10uM; HL60; HG-U133A | 1.36e-04 | 198 | 90 | 6 | 369_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; HL60; HT_HG-U133A | 1.36e-04 | 198 | 90 | 6 | 3117_DN | |
| Drug | Sarin | 1.41e-04 | 286 | 90 | 7 | ctd:D012524 | |
| Drug | gallopamil | 1.45e-04 | 67 | 90 | 4 | CID000001234 | |
| Disease | Autosomal dominant polycystic kidney disease | 2.75e-05 | 3 | 90 | 2 | cv:C0085413 | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 5.50e-05 | 4 | 90 | 2 | C4551898 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 5.50e-05 | 4 | 90 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | total blood protein measurement | 7.04e-05 | 449 | 90 | 8 | EFO_0004536 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.82e-04 | 36 | 90 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Polycystic kidney disease, type 2 | 1.91e-04 | 7 | 90 | 2 | C2751306 | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 2.55e-04 | 8 | 90 | 2 | C0887850 | |
| Disease | Charcot-Marie-Tooth disease | 2.89e-04 | 42 | 90 | 3 | cv:C0007959 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 3.27e-04 | 9 | 90 | 2 | C0085413 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 4.97e-04 | 11 | 90 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | pulse pressure measurement | VAC14 FAM193A MARK3 SUPT6H PKD1 FER ABCB11 ZBTB41 ACAD10 CDK14 CCNYL2 PLCE1 | 1.06e-03 | 1392 | 90 | 12 | EFO_0005763 |
| Disease | Myopia | 1.18e-03 | 385 | 90 | 6 | HP_0000545 | |
| Disease | coagulation factor measurement | 1.69e-03 | 20 | 90 | 2 | EFO_0004634 | |
| Disease | Granulomatous Slack Skin | 2.04e-03 | 22 | 90 | 2 | C0376407 | |
| Disease | amblyopia | 2.04e-03 | 22 | 90 | 2 | MONDO_0001020 | |
| Disease | hippocampal volume | 2.19e-03 | 297 | 90 | 5 | EFO_0005035 | |
| Disease | Renal glomerular disease | 2.23e-03 | 23 | 90 | 2 | C0268731 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 2.23e-03 | 23 | 90 | 2 | C0079773 | |
| Disease | Glomerulopathy Assessment | 2.23e-03 | 23 | 90 | 2 | C4521256 | |
| Disease | Immunologic Deficiency Syndromes | 2.23e-03 | 23 | 90 | 2 | C0021051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDKASIMRLAISFLR | 51 | Q99814 | |
| KERLLRISIRHMVKS | 461 | Q15878 | |
| QRLVKRMTRFFTKLD | 371 | O14757 | |
| QVFAMARLRFLKLKR | 836 | Q8N139 | |
| ARKRTAKRAALMILT | 131 | P28566 | |
| RALALMKARVKSRLA | 931 | Q6JQN1 | |
| LLTKRLRKFGFRAML | 826 | O95342 | |
| KSRFAIRKIMLLEFS | 56 | O60306 | |
| RRLKFSQIELMLRKA | 176 | Q5VYY1 | |
| MKKLRRTLSESFSRI | 16 | O94921 | |
| MKTLRARFKKTELRL | 1 | Q8TF21 | |
| RVRRFDLLKRILKMD | 61 | O15519 | |
| YAEMREKLRLRLTKR | 811 | P78312 | |
| LMMRRRFLSLKKTAI | 2276 | Q8IZT6 | |
| ILRHKTSGKIRLLMR | 1221 | P49792 | |
| IRLLMRRDKTLKICA | 86 | P43487 | |
| LEFRKARSDMLLSRK | 151 | O75323 | |
| LDKKLMSDLRRKRTA | 321 | Q96HW7 | |
| KRTTFLKKHRMLGRL | 621 | Q8WYB5 | |
| RLFRVMRLVKLLSKG | 1296 | O60840 | |
| EVRNALMKLLRRKIS | 296 | Q8NGM9 | |
| LMGLFEKRRFRKFLV | 131 | P50395 | |
| DRREFIDLLKKMLTI | 496 | Q9H2X6 | |
| HLAAKLANRRMKRIL | 96 | Q5H8A3 | |
| MLSRIEKQLKRRFAI | 671 | P33992 | |
| MIDRRLRKNLKSLII | 256 | Q86WG3 | |
| RAMLKRLLRIDSKCL | 486 | Q92993 | |
| LFRRGSLLGSMKLRK | 211 | Q9HDC5 | |
| VLKHSLLSFKRRRAM | 1376 | Q5H9U9 | |
| LLSFKRRRAMETLKL | 1381 | Q5H9U9 | |
| KLIFRFVRTLFKAMR | 191 | Q5T2Q4 | |
| MNRRRKFLLASVLAL | 1 | Q8IXT1 | |
| RKSAKFRSISRSLML | 11 | Q14005 | |
| KLKTRNRESISLLMR | 1076 | P55160 | |
| LMRIFRVLKLARHST | 346 | Q96KK3 | |
| MKKFKRRLSLTLRGS | 1 | Q00537 | |
| EAKMELKRRLSRKLS | 546 | O75167 | |
| MLRKLRRSLRTVLES | 311 | Q9Y5Y4 | |
| STMKAFRDLFLRALK | 911 | Q27J81 | |
| LRNKDMKGALRRLLA | 296 | Q5JQS5 | |
| VSFRAADIRRKLLML | 916 | Q13315 | |
| IMRILRILKLARHST | 301 | Q14721 | |
| FRLFRVMRLVKLLSR | 1376 | Q13936 | |
| LTLSKIRSLKREMRK | 511 | Q8TDN4 | |
| FEIKKLALDRMRLST | 96 | Q9H3R5 | |
| ELRLLETVKKFMALR | 21 | P16591 | |
| LKRLRDAKSLAEMLI | 1621 | Q8TD84 | |
| KLTRRNMSFRFIKRL | 611 | P27448 | |
| RSFRSKRSKMLLEIN | 326 | Q15051 | |
| LKMERSFFLKKRRAD | 256 | Q8IYD2 | |
| AARRKARRLLKTVLM | 241 | O95977 | |
| KLTLSKIRSLKREMR | 356 | Q9BTV7 | |
| AMKRAALLEKRLRRE | 1176 | Q08AD1 | |
| AMKLRRVQKALRLDL | 406 | Q13474 | |
| ARKVKRLHGMLRSLL | 3661 | P98161 | |
| VLKTRMEERRLRAKL | 181 | Q9BY42 | |
| MINLLKRFSSERKLL | 531 | Q08AM6 | |
| ERRLLKKTMSGTFLL | 586 | P52630 | |
| TSLVILMLARRKERL | 691 | Q8TEL6 | |
| SLIDKRIKLYMRRLL | 436 | Q8N4U5 | |
| LLGFARLIKRMRKTQ | 456 | Q6ZSM3 | |
| GLLELTRAVRKMRKF | 1001 | Q9P212 | |
| TMLERLASKRRKLVA | 451 | Q14697 | |
| GFISVLKLFRMRSLR | 261 | P22732 | |
| LMRIFRILKLARHST | 381 | Q8TDN2 | |
| RLMKMARLLARFLRE | 116 | Q9Y4R8 | |
| LRMTFCKALILLRNK | 96 | Q9NVU7 | |
| SLATMIDRIKRHLKL | 261 | Q9GZT8 | |
| KEDLLRRLKLVKMYR | 166 | Q86XK3 | |
| ESQKLLRKKARRMLR | 1071 | Q14028 | |
| LRIRKENLTRLFEKM | 406 | Q7KZ85 | |
| RSMRTVKRETLKLIS | 746 | O14980 | |
| ALILILKRLDRMFNK | 2581 | Q8N2C7 | |
| LEKDIATKMRLRALS | 386 | Q9NXC5 | |
| LTKRDQMKLDSILRR | 331 | Q9Y5K1 | |
| DAFNLLLEMKLKRRR | 41 | Q9H4I3 | |
| KSLVASMRRFSLLKR | 76 | Q8N4C7 | |
| LRTLLRSSEMRRKLL | 21 | P0C7P2 | |
| LKMLERSFSARRSKR | 241 | Q5SVQ8 | |
| LVFVRKLMDLLFTKR | 1016 | Q6U841 | |
| RMRVLSKAFSRLKTT | 91 | O43680 | |
| KSLRRKRSMGFIIEI | 3981 | Q86WI1 | |
| RRKTMKLCRELSDLV | 591 | Q4KWH8 | |
| LRRLMKEKQRLSTSR | 21 | Q96NB3 | |
| MELKSFRTLRALRPL | 1141 | Q9UI33 | |
| LLFLFSRMLLVAKRR | 336 | Q9H7P9 | |
| LREKDRLLAMAVIRK | 296 | Q96EK4 | |
| MLLREELLKSLANKR | 626 | O60293 | |
| RLLTAMRKRKLSQLH | 806 | Q08AF3 | |
| DKFLLFARRMDIRRI | 741 | O75096 | |
| MLKARRELKALRIEA | 896 | Q9ULV0 | |
| LKKVMDLSIVRLRFS | 181 | Q00653 |